Author:
Diamond Bruce J.,Kolak Julia
Publisher
Springer International Publishing
Reference19 articles.
1. Adjou, K. T., Simoneau, S., Sales, N., Lamoury, F., Dormont, D., Papy-Garcia, D., et al. (2003). A novel generation of heparan sulfate mimetics for the treatment of prion disease. Journal of General Virology, 84, 2595–2603.
2. Barrett, A., Tagliavini, F., Forloni, G., Bate, C., Salmona, M., Colombo, L., et al. (2003). Evaluation of quinacrine treatment for prion diseases. Journal of Virology, 77, 8462–8469.
3. Belay, E. D., & Schonberger, L. B. (2005). The public health impact of prion diseases. Annual Review of Public Health, 26, 191–212.
4. Chusid, J. G., & McDonald, J. J. (1973). Correlative neuroanatomy and functional neurology. San Francisco: Lange Medical Publications.
5. Collinge, J. (1997). Human prion diseases and bovine spongiform encephalopathy (BSE). Human Molecular Genetics, 6, 1699–1705.